Substances or substance mixtures which alter the function of the endocrine system and consequently causes adverse health effects in an intact organism, or its progeny, or in (sub)populations are ...

Lack of data from the chemical industry in the EU often prevents the assessment of whether substances, for example, used in consumer products, are endocrine disrupting. As a result, the researchers ...

Dr Josef Köhrle, discusses with Lorna Rothery the urgent need for stronger actions to address the potential health risks posed by these chemicals ...

Endocrine disruptors are substances that interfere with the endocrine system. They are present in products such as food and beverage packaging, cosmetics, and flame-retardant chemicals. The endocrine ...

The endocrine system is a network of glands that produces all the hormones used by the body. In addition to well-known sex hormones like testosterone and estrogen, it also secretes important hormones ...

The endocrine system is the name for the glands that produce hormones in a person’s body. These glands include the thyroid gland, pituitary gland, and adrenal gland. The endocrine system produces ...

When these hormones become imbalanced, it can lead to the development of an endocrine disorder. “An endocrine disorder occurs when your body produces either too much or too little of a particular ...

What Is the Endocrine System? The endocrine system is a network of glands in your body that make the hormones that help cells talk to each other. They’re responsible for almost every cell, organ, and ...

Impact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non–Small-Cell Lung Cancer We show that aberrations of genes in these ...

The endocrine system uses chemical messengers called hormones to regulate a range of bodily functions through the release of hormones. The endocrine system is a network of glands and organs located ...

As a result, the researchers recommend updating the information requirements in the EU legislation, REACH. They also propose various approaches for evaluating chemical substances to ensure that all ...

Impact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non–Small-Cell Lung Cancer A need exists for improvements in the clinical ...